Governor Sisolak announced yesterday a total of 588,216 Flexflow COVID-19 Antigen home tests are on the way to the State of Nevada. The first deliveries will be made directly to community partners who will help ensure the tests reach Nevadans in high need communities as quickly as possible. This is the State’s first order of at-home rapid tests and additional orders will follow. The kits will help meet a growing need for testing as the virus surges with the spread of the highly contagious Omicron variant.
The Nevada Health Response website recently expanded the COVID-19 treatment page with more information on the different types of treatments available and how to locate them. The State is still receiving limited treatments from the federal government but is working alongside the State Board of Pharmacy and other partners to request more product and to ensure Nevadans have access to these treatments. Several monoclonal antibody treatments have been authorized by the federal Food & Drug Administration (FDA) for emergency use authorization (EUA) to treat high-risk patients who have contracted or been exposed to COVID-19. Monoclonal antibodies should be initiated as soon as possible but within 10 days of symptom onset or positive test.
The Governor and the Nevada Legislature have approved allocating $19.6 million to support an increase in access to monoclonal antibody treatment and other COVID-19 treatments throughout Nevada.
News from the Governor’s Office
State Agency and Local Government Updates
Articles of Interest